Still no evidence for causes of Alzheimer's disease by playing football, despite NFL settlement

NewsGuard 100/100 Score

Despite the NFL's $765 million settlement with retired players, there still is no credible scientific evidence that playing football causes Alzheimer's disease or other neurological disorders, according to Loyola University Medical Center clinical neuropsychologist Christopher Randolph, PhD, who has published multiple studies on the topic.

"The lawsuit is not a scientific issue, it's a legal and political issue," Randolph said. "There is absolutely no credible scientific data to suggest an increase of neurological risk from playing professional football."

Under the tentative settlement, the NFL would pay up to $5 million for each player who has Alzheimer's disease and up to $4 million for each death from chronic traumatic encephalopathy (CTE). But a recent study by Randolph and colleagues of retired NFL football players found no evidence that CTE even exists. The study was published in the Journal of the International Neuropsychological Society.

Randolph said there currently are no conclusive data that retired NFL players suffer a unique neuropathology. CTE is a vague condition, with no established clinical criteria and no consistent pathological criteria to diagnose it. And recent studies have found that NFL players have overall mortality rates that are only half of expected rates based upon men in the general population. Suicide rates are only about 40 percent of the rates in the general population.

"We still do not know if NFL players have an increased risk of late-life neurodegenerative disorders," Randolph said. "If there is a risk, it probably is not a great risk. And there is essentially no evidence to support the existence of any unique clinical disorder such as CTE."

Source: Loyola University Medical Center

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers develop novel exosome-based drug delivery system to treat Alzheimer's disease